JTCS Click here to go to SJM website.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
David H. Adams
Ani C. Anyanwu
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Adams, D. H.
Right arrow Articles by Anyanwu, A. C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Adams, D. H.
Right arrow Articles by Anyanwu, A. C.
Related Collections
Right arrow Valve disease

J Thorac Cardiovasc Surg 2008;136:551-556
© 2008 The American Association for Thoracic Surgery


Editorial

Seeking a Higher Standard for Degenerative Mitral Valve Repair: Begin with Etiology

David H. Adams, MD*, Ani C. Anyanwu, MD

Department of Cardiothoracic Surgery, Mount Sinai Medical Center, New York, NY

Received for publication October 8, 2007; accepted for publication October 19, 2007.

* Address for reprints: David H. Adams, MD, Professor and Chairman, Department of Cardiothoracic Surgery, Mount Sinai Medical Center, 1190 Fifth Avenue, New York, NY 10029, Telephone 212 659 6820, Fax 212 659 6818. (Email: david.adams@mountsinai.org).

The first 300 words of the full text of this article appear below.

Despite the widely held consensus that valve repair is the preferred surgical treatment for patients suffering from degenerative mitral valve disease, valve replacement for this condition remains all too prevalent. In the past few years interest in mitral valve repair has expanded among cardiologists and surgeons, with the recognition that asymptomatic patients with severe mitral regurgitation may be candidates for surgery provided they are likely to undergo valve repair and obtain a durable result. We address both issues in the context of a recent article published in the Journal, which explored the results of mitral valve repair in degenerative disease according to etiologic classification – Barlow's disease or fibroelastic deficiency.1Go Most reports in the mitral valve repair literature define patient subsets on the basis of leaflet dysfunction (posterior, anterior or bileaflet prolapse) and repair techniques (chordal shortening or artificial chordoplasty; annuloplasty ring or no annuloplasty ring, etc.), without clarification of the etiology of degenerative disease. Furthermore, these studies traditionally used patient survival and freedom from re-operation as the principal indicators of a durable result.2-4Go Recently, however, it has been appreciated that a proportion of patients free from reoperation after mitral valve repair have significant recurrent mitral regurgitation5,6Go implying that freedom from reoperation is not a robust measure of durability of mitral valve repair.

In their recent article, Flameng and co-workers1Go introduced a fresh dimension into mitral valve repair outcomes research, by attempting to define the long-term outcome of mitral valve repair, including the freedom from recurrent mitral regurgitation, on the basis of etiology of degenerative mitral valve disease. Their data suggest, perhaps surprisingly, that, provided the surgical techniques were optimal, patients have a similar rate of recurrent regurgitation after mitral valve repair regardless of whether the original disease was Barlow's or fibroelastic deficiency. There are several limitations in their . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
M. Padala, R. A. Hutchison, L. R. Croft, J. H. Jimenez, R. C. Gorman, J. H. Gorman III, M. S. Sacks, and A. P. Yoganathan
Saddle shape of the mitral annulus reduces systolic strains on the p2 segment of the posterior mitral leaflet.
Ann. Thorac. Surg., November 1, 2009; 88(5): 1499 - 1504.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
J. Seeburger, M. A. Borger, N. Doll, T. Walther, J. Passage, V. Falk, and F. W. Mohr
Comparison of outcomes of minimally invasive mitral valve surgery for posterior, anterior and bileaflet prolapse
Eur. J. Cardiothorac. Surg., September 1, 2009; 36(3): 532 - 538.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
L. A. Bockeria, I. I. Skopin, and I. M. Tsiskaridze
eComment: Should triangular resection be an adequate approach for prolapsing posterior leaflet in all types of degenerative mitral valve disease?
Interactive CardioVascular and Thoracic Surgery, August 1, 2009; 9(2): 290 - 290.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. H. Adams, A. C. Anyanwu, J. Chikwe, and F. Filsoufi
The Year in Cardiovascular Surgery
J. Am. Coll. Cardiol., June 23, 2009; 53(25): 2389 - 2403.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2008 by The American Association for Thoracic Surgery.